Exercise Induced Asthma
14
1
1
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.1%
1 terminated out of 14 trials
88.9%
+2.4% vs benchmark
14%
2 trials in Phase 3/4
38%
3 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (14)
Inspiratory Muscle Training on The Severity of Exercise-Induced Bronchoconstriction and Time-Trial Performance (IMT_EIB)
The Rainbow Study - the Effect of Feedback on Asthmatic Symptom Perception
Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911)
Kt and Myofascial Release in Exc Asthma
A Prospective Study Measuring Exhaled Nitric Oxide in Exercise-Induced Asthma
Adaptation to Ozone in Individuals With Asthma/Exercise-induced Bronchoconstriction
Epigenetic Regulation of Exercise Induced Asthma
Evaluation of Exercise Induced Bronchoconstriction Using a Novel Automated Digital Clinical Decision System
Trial on the Effect of Budesonide/Formoterol and Inhaled Budesonide Alone on Exercise-Induced Asthma
Diagnostics and Quality of Life With EIA and EILO
Mediator Release During Exercise-induced Bronchoconstriction
Study of Airway Inflammation in Relation to Exercise in Elite Athletes
Comparing Symbicort® As-Needed or Bricanyl As-Needed or Pulmicort® Once Daily + Bricanyl As-Needed in Asthma Patients
Study to Assess Safety and Efficacy of Oral Senicapoc Administration on Exercise-induced Asthma